22 November 2013
Previous studies have demonstrated the potential beneficial effect of N-acetylcysteine (NAC) in chronic obstructive pulmonary disease (COPD). However, the required dose and responder phenotype remain unclear. The current study investigated the effect of high-dose NAC on airway geometry, inflammation, and oxidative stress in COPD patients. Novel functional respiratory imaging methods combining multislice computed tomography images and computer-based flow simulations were used with high sensitivity for detecting changes induced by the therapy.
Twelve patients with Global Initiative for Chronic Obstructive Lung Disease stage II COPD were randomized to receive NAC 1800 mg or placebo daily for 3 months and were then crossed over to the alternative treatment for a further 3 months.
Significant correlations were found between image-based resistance values and glutathione levels after treatment with NAC ( P = 0.011) and glutathione peroxidase at baseline ( P = 0.036). Image-based resistance values appeared to be a good predictor for glutathione peroxidase levels after NAC ( P = 0.02), changes in glutathione peroxidase levels ( P = 0.035), and reduction in lobar functional residual capacity levels ( P = 0.00084). In the limited set of responders to NAC therapy, the changes in airway resistance were in the same order as changes induced by budesonide/formoterol.